Prevalence of left atrial thrombus in patients with non-valvular atrial fibrillation: A systematic review and meta-analysis of the literature

Thrombosis and Haemostasis

Volumn 115, Issue 3, 2016, Pages 663-677

  Di Minno, Matteo Nicola Dario ^a   Ambrosino, Pasquale ^b   Russo, Antonio Dello ^a   Casella, Michela ^a   Tremoli, Elena ^a   Tondo, Claudio ^a  

^a CENTRO CARDIOLOGICO MONZINO   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Atrial fibrillation; Left atrial thrombus; Transesophageal echocardiography

Indexed keywords

ANTICOAGULANT AGENT;

ABLATION THERAPY; ANTICOAGULATION; ARTERY EMBOLISM; ARTERY THROMBOSIS; ATRIAL FIBRILLATION; CARDIOVASCULAR RISK; CARDIOVERSION; CHADS2 SCORE; DIABETES MELLITUS; FEMALE; GENETIC HETEROGENEITY; HEART FAILURE; HUMAN; HYPERTENSION; MALE; META ANALYSIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; AGED; BLOOD; CEREBROVASCULAR ACCIDENT; CHEMISTRY; CHRONIC DISEASE; COMPLICATION; DIABETES COMPLICATIONS; HEART ATRIUM; MIDDLE AGED; ODDS RATIO; PATHOPHYSIOLOGY; REGRESSION ANALYSIS; THROMBOSIS;

AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; CHRONIC DISEASE; DIABETES COMPLICATIONS; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; HEART ATRIA; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; REGRESSION ANALYSIS; STROKE; THROMBOSIS;

EID: 84964797868     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH15-07-0532     Document Type: Review

References (96)

1. Zoni-Berisso M, et al. Frequency, patient characteristics, treatment strategies, and resource usage of atrial fibrillation (from the Italian Survey of Atrial Fibrillation Management (ISAF) study). Am J Cardiol 2013; 111: 705–711.
2. Wann LS, et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 2011; 57: 1330–1337.
3. Calkins H, et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm. 2012; 9: e21.632–696.e21.
4. Scherr D, et al. Incidence and predictors of periprocedural cerebrovascular accident in patients undergoing catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2009; 20: 1357–1363.
5. Lown B, et al. “Cardioversion” of atrial fibrillation: a report on the treatment of 65 episodes in 50 patients. N Engl J Med 1963; 269: 325–331.
6. Jensen JB, Humphries JO, Kouwenhoven WB, et al. Electroshock for atrial flutter and atrial fibrillation: follow-up studies on 50 patients. J Am Med Assoc 1965; 194: 1181–1184.
7. Vazquez SR, et al. Peri-procedural anticoagulation in patients undergoing ablation for atrial fibrillation. Thromb Res 2010; 126: e69–e77.
8. Fuster V, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114: e257–e354.
9. Chimowitz MI, et al. Left atrial spontaneous echo contrast is highly associated with previous stroke in patients with atrial fibrillation or mitral stenosis. Stroke 1993; 24: 1015–1019.
10. Camm AJ, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 2012; 33: 2719–2747.
11. January CT, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2014; 64: e1–76.
12. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994; 154: 1449–1457.
13. Scherr D, et al. Incidence and predictors of left atrial thrombus prior to catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2009; 20: 379–384.
14. Moher D, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLOS Medicine 2009; 6: e1000097.
15. Juni P, et al. The hazards of scoring the quality of clinical trials for meta-analysis. J Am Med Assoc 1999; 282: 1054–1060.
16. Higgins JP, et al. Measuring inconsistency in meta-analyses. Br Med J 2003; 327: 557–560.
17. Sterne JA, et al. Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis. Br Med J 2001; 323: 101–105.
18. Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000; 56: 455–463.
19. Abe Y, et al. Prediction of embolism in atrial fibrillation: classification of left atrial thrombi by transesophageal echocardiography. Jpn Circ J 2000; 64: 411–415.
20. Abe Y, et al. Embolic attack in patients with atrial fibrillation and atrial thrombus depends on the character of the thrombus. Circ J 2003; 67: 203–208.
21. Achenbach S, et al. Electron beam computed tomography for the detection of left atrial thrombi in patients with atrial fibrillation. Heart 2004; 90: 1477–1478.
22. Akoum N, et al. Association of atrial fibrosis quantified using LGE-MRI with atrial appendage thrombus and spontaneous contrast on transesophageal echocardiography in patients with atrial fibrillation. J Cardiovasc Electrophysiol 2013; 24: 1104–1109.
23. Archer SL, et al. Role of transesophageal echocardiography in the detection of left atrial thrombus in patients with chronic nonrheumatic atrial fibrillation. Am Heart J 1995; 130: 287–295.
24. Bollmann A, et al. Atrial fibrillatory rate and risk of left atrial thrombus in atrial fibrillation. Europace 2007; 9: 621–626.
25. Boyd AC, et al. Left ventricular mass predicts left atrial appendage thrombus in persistent atrial fibrillation. Eur Heart J Cardiovasc Imaging 2013; 14: 269–275.
26. Bozdemir V, et al. The association of beta-fibrinogen 455 G/A gene polymorphism with left atrial thrombus and severe spontaneous echo contrast in atrial fibrillation. Anadolu Kardiyol Derg 2010; 10: 209–215.
27. Brown J, Sadler DB. Left atrial thrombi in non-rheumatic atrial fibrillation: assessment of prevalence by transesophageal echocardiography. Int J Card Imaging 1993; 9: 65–72.
28. Choi BH, et al. Detection of left atrial thrombus in patients with mitral stenosis and atrial fibrillation: retrospective comparison of two-phase computed tomography, transoesophageal echocardiography and surgical findings. Eur Radiol 2013; 23: 2944–2953.
29. Corrado G, et al. Atrial thrombi resolution after prolonged anticoagulation in patients with atrial fibrillation. Chest 1999; 115: 140–143.
30. Corrado G, et al. Prevalence of atrial thrombi in patients with atrial fibrillation/ flutter and subtherapeutic anticoagulation prior to cardioversion. Eur J Echocardiogr 2004; 5: 257–261.
31. Cresti A, et al. Frequency and significance of right atrial appendage thrombi in patients with persistent atrial fibrillation or atrial flutter. J Am Soc Echocardiogr 2014; 27: 1200–1207.
32. Dawn B, et al. Cardiovascular death in patients with atrial fibrillation is better predicted by left atrial thrombus and spontaneous echocardiographic contrast as compared with clinical parameters. J Am Soc Echocardiogr 2005; 18: 199–205.
33. Decker JM, et al. CHADS(2) score is predictive of left atrial thrombus on precardio version transesophageal echocardiography in atrial fibrillation. Am J Cardiovasc Dis 2011; 1: 159–165.
34. Dorenkamp M, et al. Detection of left atrial thrombus during routine diagnostic work-up prior to pulmonary vein isolation for atrial fibrillation: role of transesophageal echocardiography and multidetector computed tomography. Int J Cardiol 2013; 163: 26–33.
35. Doukky R, et al. B-type natriuretic peptide predicts left atrial appendage thrombus in patients with nonvalvular atrial fibrillation. Echocardiography 2013; 30: 889–895.
36. Doukky R, et al. External validation of a novel transthoracic echocardiographic tool in predicting left atrial appendage thrombus formation in patients with nonvalvular atrial fibrillation. Eur Heart J Cardiovasc Imaging 2013; 14: 876–881.
37. Doukky R, et al. The value of diastolic function parameters in the prediction of left atrial appendage thrombus in patients with nonvalvular atrial fibrillation. Cardiovasc Ultrasound 2014; 12: 10.
38. Fukuda S, et al. Left atrial thrombus and prognosis after anticoagulation therapy in patients with atrial fibrillation. J Cardiol 2011; 58: 266–277.
39. Gökçe M, et al. Factor V Leiden mutation and its relation to left atrial thrombus in chronic nonrheumatic atrial fibrillation. Jpn Heart J 2003; 44: 481–491.
40. Gu J, Jia F, Feng P. CHADS2versus CHA2DS2-VASc scoring systems for predicting left atrial thrombus in patients with nonvalvular atrial fibrillation. Nan Fang Yi Ke Da Xue Xue Bao 2014; 34: 1601–1605.
41. Habara S, et al. Prediction of left atrial appendage thrombi in non-valvular atrial fibrillation. Eur Heart J 2007; 28: 2217–2222.
42. Hur J, et al. Dual-enhancement cardiac computed tomography for assessing left atrial thrombus and pulmonary veins before radiofrequency catheter ablation for atrial fibrillation. Am J Cardiol 2013; 112: 238–244.
43. Igarashi Y, et al. Elevated serum lipoprotein(a) is a risk factor for left atrial thrombus in patients with chronic atrial fibrillation: a transesophageal echocardiographic study. Am Heart J 1998; 136: 965–971.
44. Iwakura K, et al. Effect of elevated left ventricular diastolic filling pressure on the frequency of left atrial appendage thrombus in patients with nonvalvular atrial fibrillation. Am J Cardiol 2011; 107: 417–422.
45. Jaber WA, et al. Comparison of ability to identify left atrial thrombus by threedimensional tomography versus transesophageal echocardiography in patients with atrial fibrillation. Am J Cardiol 2004; 93: 486–489.
46. Jung PH, et al. Contrast enhanced transesophageal echocardiography in patients with atrial fibrillation referred to electrical cardioversion improves atrial thrombus detection and may reduce associated thromboembolic events. Cardiovasc Ultrasound 2013; 11: 1.
47. Kapa S, et al. ECG-gated dual-source CT for detection of left atrial appendage thrombus in patients undergoing catheter ablation for atrial fibrillation. J Interv Card Electrophysiol 2010; 29: 75–81.
48. Keçoğlu S, et al. The effects of eosinophil on the left atrial thrombus in patients with atrial fibrillation. Clin Appl Thromb Hemost 2014; 20: 285–289.
49. Khan MN, et al. Low incidence of left atrial or left atrial appendage thrombus in patients with paroxysmal atrial fibrillation and normal EF who present for pulmonary vein antrum isolation procedure. J Cardiovasc Electrophysiol 2008; 19: 356–358.
50. Kimura M, et al. Effect of low-intensity warfarin therapy on left atrial thrombus resolution in patients with nonvalvular atrial fibrillation: a transesophageal echocardiographic study. Jpn Circ J 2001; 65: 271–274.
51. Kleemann T, et al. Prevalence of left atrial thrombus and dense spontaneous echo contrast in patients with short-term atrial fibrillation < 48 hours undergoing cardioversion: value of transesophageal echocardiography to guide cardioversion. J Am Soc Echocardiogr 2009; 22: 1403–1408.
52. Kleemann T, et al. Prevalence and clinical impact of left atrial thrombus and dense spontaneous echo contrast in patients with atrial fibrillation and low CHADS2 score. Eur J Echocardiogr 2009; 10: 383–388.
53. Maehama T, et al. Systemic inflammation and left atrial thrombus in patients with non-rheumatic atrial fibrillation. J Cardiol 2010; 56: 118–124.
54. Maltagliati A, et al. Usefulness of multiplane transesophageal echocardiography in the recognition of artifacts and normal anatomical variants that may mimic left atrial thrombi in patients with atrial fibrillation. Ital Heart J 2003; 4: 797–802.
55. Maltagliati A, et al. Multidetector computed tomography vs multiplane transesophageal echocardiography in detecting atrial thrombi in patients candidate to radiofrequency ablation of atrial fibrillation. Int J Cardiol 2011; 152: 251–254.
56. Manning WJ, et al. Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi. N Engl J Med 1993; 328: 750–755.
57. Manning WJ, et al. Prevalence of residual left atrial thrombi among patients with acute thromboembolism and newly recognized atrial fibrillation. Arch Intern Med 1995; 155: 2193–2198.
58. Martinez MW, et al. Utility of nongated multidetector computed tomography for detection of left atrial thrombus in patients undergoing catheter ablation of atrial fibrillation. JACC Cardiovasc Imaging 2009; 2: 69–76.
59. Mazouz B, et al. Age: a riskChenzbraun Aleft atrial thrombus in atrial fibrillation. Heart 2008; 94: 197–199.
60. McCready JW, et al. Incidence of left atrial thrombus prior to atrial fibrillation ablation: is pre-procedural transoesophageal echocardiography mandatory? Europace 2010; 12: 927–932.
61. Nair CK, et al. Thromboembolism in patients with atrial fibrillation with and without left atrial thrombus documented by transesophageal echocardiography. Am J Ther 2009; 16: 385–392.
62. Nakajima K. The relationship between left atrial thrombus and hematological markers in patients with chronic non-rheumatic atrial fibrillation. Nihon Ronen Igakkai Zasshi 2000; 37: 903–907.
63. Narumiya T, et al. Relationship between left atrial appendage function and left atrial thrombus in patients with nonvalvular chronic atrial fibrillation and atrial flutter. Circ J 2003; 67: 68–72.
64. Rader VJ, et al. Clinical predictors of left atrial thrombus and spontaneous echocardiographic contrast in patients with atrial fibrillation. J Am Soc Echocardiogr 2007; 20: 1181–1185.
65. Ren JF, et al. Left atrial thrombus associated with ablation for atrial fibrillation: identification with intracardiac echocardiography. J Am Coll Cardiol 2004; 43: 1861–1867.
66. Saeed M, et al. Role of transesophageal echocardiography guided cardioversion in patients with atrial fibrillation, previous leftatrial thrombus and effective anticoagulation. Int J Cardiol 2006; 113: 401–405.
67. Sakai M, et al. Examinations to detect left atrial thrombus and blood coagulation test analyses in aged patients with atrial fibrillation. Nihon Ronen Igakkai Zasshi 1994; 31: 447–455.
68. Shen X, et al. Prevalence of intra-atrial thrombi in atrial fibrillation patients with subtherapeutic international normalized ratios while taking conventional anticoagulation. Am J Cardiol 2002; 90: 660–662.
69. Shen X, et al. Transesophageal echocardiography before cardioversion of recurrent atrial fibrillation: does absence of previous atrial thrombi preclude the need of a repeat test? Am Heart J 2003; 146: 741–745.
70. Somlói M, et al. D-dimer determination as a screening tool to exclude atrial thrombi in atrial fibrillation. Am J Cardiol 2003; 92: 85–87.
71. Srimannarayana J, et al. Prevalence of left atrial thrombus in rheumatic mitral stenosis with atrial fibrillation and its response to anticoagulation: a transesophageal echocardiographic study. Indian Heart J 2003; 55: 358–361.
72. Stoddard MF, et al. Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study. J Am Coll Cardiol 1995; 25: 452–429.
73. Stoddard MF, et al. Left atrial thrombus predicts transient ischemic attack in patients with atrial fibrillation. Am Heart J 2003; 145: 676–682.
74. Stöllberger C, et al. Transesophageal echocardiography to assess embolic risk in patients with atrial fibrillation. ELAT Study Group. Embolism in Left Atrial Thrombi. Ann Intern Med 1998; 128: 630–638.
75. Stöllberger C, et al. Mortality and rate of stroke or embolism in atrial fibrillation during long-term follow-up in the embolism in left atrial thrombi (ELAT) study. Clin Cardiol 2004; 27: 40–46.
76. Tang RB, et al. Comparison of contrast enhanced 64-slice computed tomography and transesophageal echocardiography in detection of left atrial thrombus in patients with atrial fibrillation. J Interv Card Electrophysiol 2008; 22: 199–203.
77. Tang RB, et al. Body mass index and risk of left atrial thrombus in patients with atrial fibrillation. Am J Cardiol 2009; 104: 1699–1703.
78. Tang RB, et al. Is CHA2DS2-VASc score a predictor of left atrial thrombus in patients with paroxysmal atrial fibrillation? Thromb Haemost 2011; 105: 1107–1109.
79. Tani T, et al. Usefulness of electron beam tomography in the prone position for detecting atrial thrombi in chronic atrial fibrillation. J Comput Assist Tomogr 2003; 27: 78–84.
80. Tsai LM, et al. Role of transesophageal echocardiography in detecting left atrial thrombus and spontaneous echo contrast in patients with mitral valve disease or non-rheumatic atrial fibrillation. J Formos Med Assoc 1990; 89: 270–274.
81. Tsai LM, et al. Prevalence and clinical significance of left atrial thrombus in nonrheumatic atrial fibrillation. Int J Cardiol 1997; 58: 163–169.
82. Uz O, et al. The CHA2DS2-VASc score as a predictor of left atrial thrombus in patients with non-valvular atrial fibrillation. Med Princ Pract 2014; 23: 234–238.
83. von der Recke G, et al. Use of transesophageal contrast echocardiography for excluding left atrial appendage thrombi in patients withatrial fibrillation before cardioversion. J Am Soc Echocardiogr 2002; 15: 1256–1261.
84. Wallace TW, et al. Prevalence and clinical characteristics associated with left atrial appendage thrombus in fully anticoagulated patients undergoing catheterdirected atrial fibrillation ablation. J Cardiovasc Electrophysiol 2010; 21: 849–852.
85. Yalcin M, et al. Neutrophil-Lymphocyte Ratio May Predict Left Atrial Thrombus in Patients With Nonvalvular Atrial Fibrillation. Clin Appl Thromb Hemost 2015; 21: 166–171.
86. Yamamoto M, et al. Complex left atrial appendage morphology and left atrial appendage thrombus formation in patients with atrial fibrillation. Circ Cardiovasc Imaging 2014; 7: 337–343.
87. Klein AL, et al. Cardioversion guided by transesophageal echocardiography: the ACUTE Pilot Study. A randomized, controlled trial. Assessment of Cardiover sion Using Transesophageal Echocardiography. Ann Intern Med 1997; 126: 200–209.
88. Klein AL, et al. Assessment of Cardioversion Using Transesophageal Echocardiography Investigators. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med 2001; 344: 1411–1420.
89. Puwanant S, et al. Role of the CHADS2 score in the evaluation of thromboembolic risk in patients with atrial fibrillation undergoing transesophageal echocardiography before pulmonary vein isolation. J Am Coll Cardiol 2009; 54: 2032–2039.
90. Mawatari K, et al. Enhancement of endothelial function inhibits left atrial thrombi development in an animal model of spontaneous left atrial thrombosis. Circ J 2014; 78: 1980–1988.
91. Dentali F, et al. Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study. Am J Hematol. 2012; 87: 384–387.
92. Dentali F, et al. Efficacy and safety of direct oral anticoagulants in patients undergoing cardioversion for atrial fibrillation: A systematic review and metaanalysis of the literature. Int J Cardiol. 2015; 185: 72–77.
93. Takasugi J, et al. Dissolution of the left atrial appendage thrombus with rivaroxaban therapy. Cerebrovasc Dis. 2013; 36: 322–323.
94. Mitamura H, et al. Left atrial thrombus formation and resolution during dabigatran therapy: A Japanese Heart Rhythm Society report. J Arrhythm 2015; 31: 226–231.
95. Lip GY, et al Rationale and design of a study exploring the efficacy of once-daily oral rivaroxaban (X-TRA) on the outcome of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation or atrial flutter and a retrospective observational registry providing baseline data (CLOT-AF). Am Heart J 2015; 169: 464–471.
96. Hur J, et al. Dual-enhanced cardiac CT for detection of left atrial appendage thrombus in patients with stroke: a prospective comparison study with transesophageal echocardiography. Stroke 2011; 42: 2471–2477.